Global Drug-Eluting Stent Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drug-Eluting Stent Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Drug-Eluting Stent by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Drug-Eluting Stent by Country/Region, 2017, 2022 & 2028

2.2 Drug-Eluting Stent Segment by Type

2.2.1 Rapamycin Eluting Stent

2.2.2 Paclitaxel Eluting Stent

2.2.3 Everolimus Eluting Stent

2.2.4 Others

2.3 Drug-Eluting Stent Sales by Type

2.3.1 Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)

2.3.2 Global Drug-Eluting Stent Revenue and Market Share by Type (2017-2022)

2.3.3 Global Drug-Eluting Stent Sale Price by Type (2017-2022)

2.4 Drug-Eluting Stent Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Ambulatory Surgical Centers

2.4.4 Others

2.5 Drug-Eluting Stent Sales by Application

2.5.1 Global Drug-Eluting Stent Sale Market Share by Application (2017-2022)

2.5.2 Global Drug-Eluting Stent Revenue and Market Share by Application (2017-2022)

2.5.3 Global Drug-Eluting Stent Sale Price by Application (2017-2022)

3 Global Drug-Eluting Stent by Company

3.1 Global Drug-Eluting Stent Breakdown Data by Company

3.1.1 Global Drug-Eluting Stent Annual Sales by Company (2020-2022)

3.1.2 Global Drug-Eluting Stent Sales Market Share by Company (2020-2022)

3.2 Global Drug-Eluting Stent Annual Revenue by Company (2020-2022)

3.2.1 Global Drug-Eluting Stent Revenue by Company (2020-2022)

3.2.2 Global Drug-Eluting Stent Revenue Market Share by Company (2020-2022)

3.3 Global Drug-Eluting Stent Sale Price by Company

3.4 Key Manufacturers Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Drug-Eluting Stent Product Location Distribution

3.4.2 Players Drug-Eluting Stent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Drug-Eluting Stent by Geographic Region

4.1 World Historic Drug-Eluting Stent Market Size by Geographic Region (2017-2022)

4.1.1 Global Drug-Eluting Stent Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Drug-Eluting Stent Annual Revenue by Geographic Region

4.2 World Historic Drug-Eluting Stent Market Size by Country/Region (2017-2022)

4.2.1 Global Drug-Eluting Stent Annual Sales by Country/Region (2017-2022)

4.2.2 Global Drug-Eluting Stent Annual Revenue by Country/Region

4.3 Americas Drug-Eluting Stent Sales Growth

4.4 APAC Drug-Eluting Stent Sales Growth

4.5 Europe Drug-Eluting Stent Sales Growth

4.6 Middle East & Africa Drug-Eluting Stent Sales Growth

5 Americas

5.1 Americas Drug-Eluting Stent Sales by Country

5.1.1 Americas Drug-Eluting Stent Sales by Country (2017-2022)

5.1.2 Americas Drug-Eluting Stent Revenue by Country (2017-2022)

5.2 Americas Drug-Eluting Stent Sales by Type

5.3 Americas Drug-Eluting Stent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drug-Eluting Stent Sales by Region

6.1.1 APAC Drug-Eluting Stent Sales by Region (2017-2022)

6.1.2 APAC Drug-Eluting Stent Revenue by Region (2017-2022)

6.2 APAC Drug-Eluting Stent Sales by Type

6.3 APAC Drug-Eluting Stent Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Drug-Eluting Stent by Country

7.1.1 Europe Drug-Eluting Stent Sales by Country (2017-2022)

7.1.2 Europe Drug-Eluting Stent Revenue by Country (2017-2022)

7.2 Europe Drug-Eluting Stent Sales by Type

7.3 Europe Drug-Eluting Stent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drug-Eluting Stent by Country

8.1.1 Middle East & Africa Drug-Eluting Stent Sales by Country (2017-2022)

8.1.2 Middle East & Africa Drug-Eluting Stent Revenue by Country (2017-2022)

8.2 Middle East & Africa Drug-Eluting Stent Sales by Type

8.3 Middle East & Africa Drug-Eluting Stent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stent

10.3 Manufacturing Process Analysis of Drug-Eluting Stent

10.4 Industry Chain Structure of Drug-Eluting Stent

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Drug-Eluting Stent Distributors

11.3 Drug-Eluting Stent Customer

12 World Forecast Review for Drug-Eluting Stent by Geographic Region

12.1 Global Drug-Eluting Stent Market Size Forecast by Region

12.1.1 Global Drug-Eluting Stent Forecast by Region (2023-2028)

12.1.2 Global Drug-Eluting Stent Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Drug-Eluting Stent Forecast by Type

12.7 Global Drug-Eluting Stent Forecast by Application

13 Key Players Analysis

13.1 Boston Scientific

13.1.1 Boston Scientific Company Information

13.1.2 Boston Scientific Drug-Eluting Stent Product Offered

13.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boston Scientific Main Business Overview

13.1.5 Boston Scientific Latest Developments

13.2 Medtronic

13.2.1 Medtronic Company Information

13.2.2 Medtronic Drug-Eluting Stent Product Offered

13.2.3 Medtronic Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Medtronic Main Business Overview

13.2.5 Medtronic Latest Developments

13.3 Abbott

13.3.1 Abbott Company Information

13.3.2 Abbott Drug-Eluting Stent Product Offered

13.3.3 Abbott Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abbott Main Business Overview

13.3.5 Abbott Latest Developments

13.4 Lepu Medical

13.4.1 Lepu Medical Company Information

13.4.2 Lepu Medical Drug-Eluting Stent Product Offered

13.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lepu Medical Main Business Overview

13.4.5 Lepu Medical Latest Developments

13.5 B. Braun Melsungen

13.5.1 B. Braun Melsungen Company Information

13.5.2 B. Braun Melsungen Drug-Eluting Stent Product Offered

13.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 B. Braun Melsungen Main Business Overview

13.5.5 B. Braun Melsungen Latest Developments

13.6 MicroPort Scientific

13.6.1 MicroPort Scientific Company Information

13.6.2 MicroPort Scientific Drug-Eluting Stent Product Offered

13.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 MicroPort Scientific Main Business Overview

13.6.5 MicroPort Scientific Latest Developments

13.7 Cook Medical

13.7.1 Cook Medical Company Information

13.7.2 Cook Medical Drug-Eluting Stent Product Offered

13.7.3 Cook Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cook Medical Main Business Overview

13.7.5 Cook Medical Latest Developments

13.8 Terumo

13.8.1 Terumo Company Information

13.8.2 Terumo Drug-Eluting Stent Product Offered

13.8.3 Terumo Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Terumo Main Business Overview

13.8.5 Terumo Latest Developments

13.9 Biosensors International

13.9.1 Biosensors International Company Information

13.9.2 Biosensors International Drug-Eluting Stent Product Offered

13.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biosensors International Main Business Overview

13.9.5 Biosensors International Latest Developments

13.10 Balton

13.10.1 Balton Company Information

13.10.2 Balton Drug-Eluting Stent Product Offered

13.10.3 Balton Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Balton Main Business Overview

13.10.5 Balton Latest Developments

13.11 AlviMedica Medical Technologies

13.11.1 AlviMedica Medical Technologies Company Information

13.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Product Offered

13.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AlviMedica Medical Technologies Main Business Overview

13.11.5 AlviMedica Medical Technologies Latest Developments

13.12 Biotronik

13.12.1 Biotronik Company Information

13.12.2 Biotronik Drug-Eluting Stent Product Offered

13.12.3 Biotronik Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Biotronik Main Business Overview

13.12.5 Biotronik Latest Developments

13.13 Shandong JW Medical

13.13.1 Shandong JW Medical Company Information

13.13.2 Shandong JW Medical Drug-Eluting Stent Product Offered

13.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shandong JW Medical Main Business Overview

13.13.5 Shandong JW Medical Latest Developments

13.14 Sino Medical

13.14.1 Sino Medical Company Information

13.14.2 Sino Medical Drug-Eluting Stent Product Offered

13.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sino Medical Main Business Overview

13.14.5 Sino Medical Latest Developments

13.15 Beijing AMSINO

13.15.1 Beijing AMSINO Company Information

13.15.2 Beijing AMSINO Drug-Eluting Stent Product Offered

13.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Beijing AMSINO Main Business Overview

13.15.5 Beijing AMSINO Latest Developments

14 Research Findings and Conclusion

Table 1. Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Drug-Eluting Stent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rapamycin Eluting Stent

Table 4. Major Players of Paclitaxel Eluting Stent

Table 5. Major Players of Everolimus Eluting Stent

Table 6. Major Players of Others

Table 7. Global Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)

Table 8. Global Drug-Eluting Stent Sales Market Share by Type (2017-2022)

Table 9. Global Drug-Eluting Stent Revenue by Type (2017-2022) & ($ million)

Table 10. Global Drug-Eluting Stent Revenue Market Share by Type (2017-2022)

Table 11. Global Drug-Eluting Stent Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)

Table 13. Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Table 14. Global Drug-Eluting Stent Revenue by Application (2017-2022)

Table 15. Global Drug-Eluting Stent Revenue Market Share by Application (2017-2022)

Table 16. Global Drug-Eluting Stent Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Drug-Eluting Stent Sales by Company (2020-2022) & (K Units)

Table 18. Global Drug-Eluting Stent Sales Market Share by Company (2020-2022)

Table 19. Global Drug-Eluting Stent Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Drug-Eluting Stent Revenue Market Share by Company (2020-2022)

Table 21. Global Drug-Eluting Stent Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Drug-Eluting Stent Producing Area Distribution and Sales Area

Table 23. Players Drug-Eluting Stent Products Offered

Table 24. Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Drug-Eluting Stent Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Drug-Eluting Stent Sales Market Share Geographic Region (2017-2022)

Table 29. Global Drug-Eluting Stent Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Drug-Eluting Stent Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Drug-Eluting Stent Sales Market Share by Country/Region (2017-2022)

Table 33. Global Drug-Eluting Stent Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Drug-Eluting Stent Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)

Table 36. Americas Drug-Eluting Stent Sales Market Share by Country (2017-2022)

Table 37. Americas Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Drug-Eluting Stent Revenue Market Share by Country (2017-2022)

Table 39. Americas Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)

Table 40. Americas Drug-Eluting Stent Sales Market Share by Type (2017-2022)

Table 41. Americas Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)

Table 42. Americas Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Table 43. APAC Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)

Table 44. APAC Drug-Eluting Stent Sales Market Share by Region (2017-2022)

Table 45. APAC Drug-Eluting Stent Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Drug-Eluting Stent Revenue Market Share by Region (2017-2022)

Table 47. APAC Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)

Table 48. APAC Drug-Eluting Stent Sales Market Share by Type (2017-2022)

Table 49. APAC Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)

Table 50. APAC Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Table 51. Europe Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)

Table 52. Europe Drug-Eluting Stent Sales Market Share by Country (2017-2022)

Table 53. Europe Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Drug-Eluting Stent Revenue Market Share by Country (2017-2022)

Table 55. Europe Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)

Table 56. Europe Drug-Eluting Stent Sales Market Share by Type (2017-2022)

Table 57. Europe Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)

Table 58. Europe Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Drug-Eluting Stent Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Drug-Eluting Stent Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Drug-Eluting Stent

Table 68. Key Market Challenges & Risks of Drug-Eluting Stent

Table 69. Key Industry Trends of Drug-Eluting Stent

Table 70. Drug-Eluting Stent Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Drug-Eluting Stent Distributors List

Table 73. Drug-Eluting Stent Customer List

Table 74. Global Drug-Eluting Stent Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Drug-Eluting Stent Sales Market Forecast by Region

Table 76. Global Drug-Eluting Stent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Drug-Eluting Stent Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Drug-Eluting Stent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Drug-Eluting Stent Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Drug-Eluting Stent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Drug-Eluting Stent Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Drug-Eluting Stent Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Drug-Eluting Stent Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Drug-Eluting Stent Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2023-2028)

Table 94. Boston Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 95. Boston Scientific Drug-Eluting Stent Product Offered

Table 96. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Boston Scientific Main Business

Table 98. Boston Scientific Latest Developments

Table 99. Medtronic Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 100. Medtronic Drug-Eluting Stent Product Offered

Table 101. Medtronic Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Medtronic Main Business

Table 103. Medtronic Latest Developments

Table 104. Abbott Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 105. Abbott Drug-Eluting Stent Product Offered

Table 106. Abbott Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Abbott Main Business

Table 108. Abbott Latest Developments

Table 109. Lepu Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 110. Lepu Medical Drug-Eluting Stent Product Offered

Table 111. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Lepu Medical Main Business

Table 113. Lepu Medical Latest Developments

Table 114. B. Braun Melsungen Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 115. B. Braun Melsungen Drug-Eluting Stent Product Offered

Table 116. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. B. Braun Melsungen Main Business

Table 118. B. Braun Melsungen Latest Developments

Table 119. MicroPort Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 120. MicroPort Scientific Drug-Eluting Stent Product Offered

Table 121. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. MicroPort Scientific Main Business

Table 123. MicroPort Scientific Latest Developments

Table 124. Cook Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 125. Cook Medical Drug-Eluting Stent Product Offered

Table 126. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Cook Medical Main Business

Table 128. Cook Medical Latest Developments

Table 129. Terumo Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 130. Terumo Drug-Eluting Stent Product Offered

Table 131. Terumo Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Terumo Main Business

Table 133. Terumo Latest Developments

Table 134. Biosensors International Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 135. Biosensors International Drug-Eluting Stent Product Offered

Table 136. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Biosensors International Main Business

Table 138. Biosensors International Latest Developments

Table 139. Balton Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 140. Balton Drug-Eluting Stent Product Offered

Table 141. Balton Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Balton Main Business

Table 143. Balton Latest Developments

Table 144. AlviMedica Medical Technologies Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 145. AlviMedica Medical Technologies Drug-Eluting Stent Product Offered

Table 146. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. AlviMedica Medical Technologies Main Business

Table 148. AlviMedica Medical Technologies Latest Developments

Table 149. Biotronik Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 150. Biotronik Drug-Eluting Stent Product Offered

Table 151. Biotronik Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Biotronik Main Business

Table 153. Biotronik Latest Developments

Table 154. Shandong JW Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 155. Shandong JW Medical Drug-Eluting Stent Product Offered

Table 156. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Shandong JW Medical Main Business

Table 158. Shandong JW Medical Latest Developments

Table 159. Sino Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 160. Sino Medical Drug-Eluting Stent Product Offered

Table 161. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Sino Medical Main Business

Table 163. Sino Medical Latest Developments

Table 164. Beijing AMSINO Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 165. Beijing AMSINO Drug-Eluting Stent Product Offered

Table 166. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. Beijing AMSINO Main Business

Table 168. Beijing AMSINO Latest Developments

List of Figures

Figure 1. Picture of Drug-Eluting Stent

Figure 2. Drug-Eluting Stent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Drug-Eluting Stent Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Drug-Eluting Stent Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Drug-Eluting Stent Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rapamycin Eluting Stent

Figure 10. Product Picture of Paclitaxel Eluting Stent

Figure 11. Product Picture of Everolimus Eluting Stent

Figure 12. Product Picture of Others

Figure 13. Global Drug-Eluting Stent Sales Market Share by Type in 2021

Figure 14. Global Drug-Eluting Stent Revenue Market Share by Type (2017-2022)

Figure 15. Drug-Eluting Stent Consumed in Hospitals

Figure 16. Global Drug-Eluting Stent Market: Hospitals (2017-2022) & (K Units)

Figure 17. Drug-Eluting Stent Consumed in Clinics

Figure 18. Global Drug-Eluting Stent Market: Clinics (2017-2022) & (K Units)

Figure 19. Drug-Eluting Stent Consumed in Ambulatory Surgical Centers

Figure 20. Global Drug-Eluting Stent Market: Ambulatory Surgical Centers (2017-2022) & (K Units)

Figure 21. Drug-Eluting Stent Consumed in Others

Figure 22. Global Drug-Eluting Stent Market: Others (2017-2022) & (K Units)

Figure 23. Global Drug-Eluting Stent Sales Market Share by Application (2017-2022)

Figure 24. Global Drug-Eluting Stent Revenue Market Share by Application in 2021

Figure 25. Drug-Eluting Stent Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Drug-Eluting Stent Revenue Market Share by Company in 2021

Figure 27. Global Drug-Eluting Stent Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Drug-Eluting Stent Revenue Market Share by Geographic Region in 2021

Figure 29. Global Drug-Eluting Stent Sales Market Share by Region (2017-2022)

Figure 30. Global Drug-Eluting Stent Revenue Market Share by Country/Region in 2021

Figure 31. Americas Drug-Eluting Stent Sales 2017-2022 (K Units)

Figure 32. Americas Drug-Eluting Stent Revenue 2017-2022 ($ Millions)

Figure 33. APAC Drug-Eluting Stent Sales 2017-2022 (K Units)

Figure 34. APAC Drug-Eluting Stent Revenue 2017-2022 ($ Millions)

Figure 35. Europe Drug-Eluting Stent Sales 2017-2022 (K Units)

Figure 36. Europe Drug-Eluting Stent Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Drug-Eluting Stent Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Drug-Eluting Stent Revenue 2017-2022 ($ Millions)

Figure 39. Americas Drug-Eluting Stent Sales Market Share by Country in 2021

Figure 40. Americas Drug-Eluting Stent Revenue Market Share by Country in 2021

Figure 41. United States Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Drug-Eluting Stent Sales Market Share by Region in 2021

Figure 46. APAC Drug-Eluting Stent Revenue Market Share by Regions in 2021

Figure 47. China Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Drug-Eluting Stent Sales Market Share by Country in 2021

Figure 54. Europe Drug-Eluting Stent Revenue Market Share by Country in 2021

Figure 55. Germany Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country in 2021

Figure 62. Egypt Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Drug-Eluting Stent Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2021

Figure 68. Manufacturing Process Analysis of Drug-Eluting Stent

Figure 69. Industry Chain Structure of Drug-Eluting Stent

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles